Marco Capobianco

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti et al. · Annals of Neurology · 2021 · 458 citations · Full text

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

Riccardo Saccardi, Tomáš Kozák, Chiara Bocelli‐Tyndall et al. · Multiple Sclerosis Journal · 2006 · 216 citations

Cell Therapy, Immunology, Immunotherapy +19

Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients

Antonio Bertolotto, Francesca Gilli, Arianna Sala et al. · Neurology · 2003 · 170 citations

Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients

Daniel Whittam, Álvaro Cobo‐Calvo, A. Sebastian López‐Chiriboga et al. · Multiple Sclerosis and Related Disorders · 2020 · 165 citations · Full text

Moxibustion, Autoimmune Disease, Immunodeficiencies +6

Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

Sven Jarius, Florence Pache, Péter Körtvelyessy et al. · Journal of Neuroinflammation · 2022 · 159 citations · Full text